RiverPark Advisors’s Lux Health Tech Acquisition Corp. Class A Common Stock LUXA Stock Holding History

RiverPark Advisors’s Portfolio LUXA Stock Details LUXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-194,879	Closed	-$1.95M	–	139
2022 Q3	$1.95M	Buy	+194,879	New	+$1.94M	0.63%	60

RiverPark Advisors's LUXA Position: Q4 2022 in Review

RiverPark Advisors sold out of Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) in Q4 2022, closing a stake of 194,879 shares — an estimated $1.95M sold.

RiverPark Advisors first reported a position in LUXA in Q3 2022 and held it in 1 quarter. The position peaked at $1.95M in Q3 2022. 0 funds tracked by Wall St. Rank hold LUXA as of Q4 2022.

RiverPark Advisors reported no remaining Lux Health Tech Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
RiverPark Advisors sold 194,879 Lux Health Tech Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $1.95M.
RiverPark Advisors first reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock in Q3 2022 and held it in 1 quarter.
RiverPark Advisors's Lux Health Tech Acquisition Corp. Class A Common Stock position peaked at $1.95M in Q3 2022.
0 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on RiverPark Advisors's 13F filing for Q4 2022, filed 10 Feb 2023.